23.10.2024 13:07:33
|
Boston Scientific Boosts FY24 Outlook - Update
(RTTNews) - While reporting financial results for the third quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and sales growth guidance for the full-year 2024. The company also provided forecast for the fourth quarter.
For fiscal 2024, the company now projects earnings in a range of $1.28 to $1.30 per share and adjusted earnings in a range of $2.45 to $2.47 per share on net sales growth of about 16.5 percent, with organic net sales growth of 15 percent.
Previously, the company expected earnings in the range of $1.34 to $1.38 per share and adjusted earnings in the range of $2.38 to $2.42 per share on net sales growth of about 13.5 to 14.5 percent, with organic net sales growth of 13 to 14 percent.
On average, 32 analysts polled by Thomson Reuters expect earnings of $2.41 per share on revenue growth of 14.4 percent to $16.29 billion for the year. Analysts' estimates typically exclude special items.
For the fourth quarter, the company estimates earnings in a range of $0.41 to $0.43 per share and adjusted earnings in a range of $0.64 to $0.66 per share on net sales growth of about 16.5 to 18.5 percent, with organic net sales growth of 14 to 16 percent.
Analysts expect earnings of $0.64 per share on revenue growth of 14.9 percent to $4.28 billion for the quarter.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Boston Scientific Corp.mehr Nachrichten
28.01.25 |
S&P 500-Papier Boston Scientific-Aktie: So viel hätten Anleger an einem Boston Scientific-Investment von vor einem Jahr verdient (finanzen.at) | |
21.01.25 |
S&P 500-Wert Boston Scientific-Aktie: So viel hätten Anleger an einem Boston Scientific-Investment von vor 10 Jahren verdient (finanzen.at) | |
21.01.25 |
Erste Schätzungen: Boston Scientific öffnet die Bücher zum abgelaufenen Quartal (finanzen.net) | |
14.01.25 |
S&P 500-Wert Boston Scientific-Aktie: So viel Gewinn hätte ein Boston Scientific-Investment von vor 5 Jahren eingefahren (finanzen.at) | |
08.01.25 |
S&P 500-Handel aktuell: S&P 500 bewegt sich zum Handelsende im Plus (finanzen.at) | |
08.01.25 |
Verluste in New York: Das macht der S&P 500 aktuell (finanzen.at) | |
08.01.25 |
Aufschläge in New York: Anleger lassen S&P 500 am Mittwochmittag steigen (finanzen.at) | |
08.01.25 |
Zurückhaltung in New York: S&P 500 präsentiert sich zum Start schwächer (finanzen.at) |
Analysen zu Boston Scientific Corp.mehr Analysen
Aktien in diesem Artikel
Boston Scientific Corp. | 100,00 | 1,52% |